126 related articles for article (PubMed ID: 34496560)
1. Discovery, Optimization, and Structure-Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma.
Yuan Y; Xu J; Jiang L; Yu K; Ge Y; Li M; He H; Niu Q; Shi X; Fan L; Chen Z; Zhao Z; Li S; Xu Y; Wang Z; Li H
J Med Chem; 2021 Sep; 64(18):13572-13587. PubMed ID: 34496560
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma.
Li MY; Fan LN; Han DH; Yu Z; Ma J; Liu YX; Li PF; Zhao DH; Chai J; Jiang L; Li SL; Xiao JJ; Duan QH; Ye J; Shi M; Nie YZ; Wu KC; Liao DJ; Shi Y; Wang Y; Yan QG; Guo SP; Bian XW; Zhu F; Zhang J; Wang Z
J Clin Invest; 2020 Aug; 130(8):4301-4319. PubMed ID: 32396532
[TBL] [Abstract][Full Text] [Related]
3. RSK4 promotes the macrophage recruitment and M2 polarization in esophageal squamous cell carcinoma.
He S; Lu M; Zhang L; Wang Z
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166996. PubMed ID: 38142759
[TBL] [Abstract][Full Text] [Related]
4. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
Tu Y; Tan F; Zhou J; Pan J
Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
[TBL] [Abstract][Full Text] [Related]
5. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
Qiu F; Liu L; Lin Y; Yang Z; Qiu F
Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
[TBL] [Abstract][Full Text] [Related]
6. Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma.
Niu F; Liu Y; Jing Z; Han G; Sun L; Yan L; Zhou L; Wu Y; Xu Y; Hu L; Zhao X
Cancer Lett; 2018 Apr; 420():60-71. PubMed ID: 29408653
[TBL] [Abstract][Full Text] [Related]
7. Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer.
Xu J; Jia Q; Zhang Y; Yuan Y; Xu T; Yu K; Chai J; Wang K; Chen L; Xiao T; Li M
Pathol Res Pract; 2021 Mar; 219():153374. PubMed ID: 33621918
[TBL] [Abstract][Full Text] [Related]
8. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
[TBL] [Abstract][Full Text] [Related]
9. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
[TBL] [Abstract][Full Text] [Related]
11. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147.
Yin Z; Cai H; Wang Z; Jiang Y
Drug Des Devel Ther; 2020; 14():4561-4573. PubMed ID: 33149553
[TBL] [Abstract][Full Text] [Related]
12. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
Luo QY; Zhou SN; Pan WT; Sun J; Yang LQ; Zhang L; Qiu MZ; Yang DJ
Biochem Pharmacol; 2021 Jan; 183():114318. PubMed ID: 33159967
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of hydroxamic acid-substituted 2,4-diaryl aminopyrimidines as potent EGFRT790M/L858R inhibitors for the treatment of NSCLC.
Chen L; Zhang Y; Wang C; Tang Z; Meng Q; Sun H; Qi Y; Ma X; Li L; Li Y; Xu Y
Bioorg Chem; 2021 Sep; 114():105045. PubMed ID: 34161879
[TBL] [Abstract][Full Text] [Related]
14. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
[TBL] [Abstract][Full Text] [Related]
16.
Yang T; Hu M; Chen Y; Xiang M; Tang M; Qi W; Shi M; He J; Yuan X; Zhang C; Liu K; Li J; Yang Z; Chen L
J Med Chem; 2020 Dec; 63(23):14921-14936. PubMed ID: 33256400
[TBL] [Abstract][Full Text] [Related]
17. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.
Liu F; Zu X; Xie X; Zhang Y; Liu K; Chen H; Wang T; Bode AM; Dong Z; Kim DJ
Cancer Prev Res (Phila); 2019 Dec; 12(12):849-860. PubMed ID: 31554627
[TBL] [Abstract][Full Text] [Related]
18. Structural Optimization and Structure-Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6
Pan S; Zhang L; Luo X; Nan J; Yang W; Bin H; Li Y; Huang Q; Wang T; Pan Z; Mu B; Wang F; Tian C; Liu Y; Li L; Yang S
J Med Chem; 2022 Feb; 65(3):2035-2058. PubMed ID: 35080890
[TBL] [Abstract][Full Text] [Related]
19. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
